LeMaitre acquires Vascular Architects.

900

LeMaitre acquires Vascular Architects.

LeMaitre Vascular has acquired the business of Vascular Architects, a privately-held medical device company, for US$2.8 million. Vascular Architects markets and sells devices for Remote Endarterectomy (RE), a hybrid open/endovascular procedure. LeMaitre did not acquire Vascular Architects’ Nashville facility or any manufacturing operations in the transaction. Vascular Architects markets a suite of six surgical and endovascular debulking tools for treating longsegment peripheral occlusive disease via RE. These six tools account for the majority of Vascular Architects’ net revenues. Five of these tools are single-use, disposable and patent protected. In addition, the company also market as the aSpire stent and also markets an implantable, helical covered stent. “We expect that the Vascular Architects products will leverage our targeted vascular surgery sales force. The expanding geographic reach of our sales force should help bring the RE procedure into the armamentarium of more vascular surgeons,” said David B Roberts, President of LeMaitre Vascular. “As is typical in our past acquisitions, the essence of the Vascular Architects transaction is about bringing together an innovative vascular product and our expanding sales force,” he added.